After watching its stock price drop earlier this week by more than 20% following the publication of a stinging report from the activist short-seller firm Scorpion Capital, the DNA weaver Twist Bioscience responded by calling the document “highly misleading” and accusing it of containing “many distortions and inaccuracies.”
Source: Twist Bioscience finds itself the target of synthetic biology short-seller Scorpion Capital
